SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-010166
Filing Date
2021-04-30
Accepted
2021-04-30 15:19:16
Documents
4
Period of Report
2021-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44605
2 ex1-1.htm EX-1.1 311107
3 ex99-1.htm EX-99.1 11981
4 ex99-2.htm EX-99.2 12040
  Complete submission text file 0001493152-21-010166.txt   381189
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12555 | Film No.: 21877162
SIC: 7389 Services-Business Services, NEC